Discover how Genentech, a pioneer in biotechnology, and NVIDIA, a leader in artificial intelligence, are collaborating to accelerate #drugdiscovery and development with generative AI. By optimizing its lab in a loop iterative framework with #generativeAI, Genentech is bridging the gap between lab experiments and computational algorithms. The impact is new molecular designs that can advance medicine and bring novel therapies to patients faster. https://www.nvidia.com/en-us/clara/biopharma/
Speakers:
Aviv Regev | EVP, Genentech Research and Early Development
John Mariono | SVP, Computational Sciences at gRED
Speakers:
Aviv Regev | EVP, Genentech Research and Early Development
John Mariono | SVP, Computational Sciences at gRED
- Category
- Hardware
- Tags
- NVIDIA, NVIDIA BioNeMo, drug discovery
Sign in or sign up to post comments.
Be the first to comment